Pang Phillip — SEC Form 4 filings
SEC reporting owner CIK 1787370. 2 Form 4 filings on record with FilingPulse; latest filed 2024-02-26.
Transaction summary — filings shown
Covers all 2 filings on record, filed 2024-02-16 to 2024-02-26. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 2 legs across 2 filings — 17,889 shares, $180,350 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 0.
- Largest priced transaction: sale of 14,568 shares @ $10.05 ($146,344) in Vir Biotechnology, Inc., filed 2024-02-26.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Vir Biotechnology, Inc. (VIR) | EVP & Chief Medical Officer | 2 | — | 2 legs · 17,889 sh · $180,350 | — |
Form 4 filings — Pang Phillip
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2024-02-26 | 4 | Vir Biotechnology, Inc. (VIR) | Sale (S): 14,568 @ $10.05 | EDGAR |
| 2024-02-16 | 4 | Vir Biotechnology, Inc. (VIR) | Sale (S): 3,321 @ $10.24 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1787370 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →